HBK Investments’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

HBK Investments’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,800	Closed	-$275K	–	1469
2018 Q3	$275K	Buy	+2,800	New	+$303K	﹤0.01%	1069
2018 Q2	–	Sell	-4,281	Closed	-$423K	–	1199
2018 Q1	$423K	Sell	4,281 -119	-3%	-$12.1K	﹤0.01%	799
2017 Q4	$461K	Buy	+4,400	New	+$483K	﹤0.01%	764
2016 Q3	–	Sell	-32,059	Closed	-$4.67M	–	1051
2016 Q2	$4.67M	Buy	32,059 +8,957	+39%	+$1.27M	0.03%	250
2016 Q1	$3.31M	Buy	23,102 +13,602	+143%	+$1.93M	0.03%	335
2015 Q4	$1.47M	Buy	9,500 +3,668	+63%	+$536K	0.01%	483
2015 Q3	$833K	Sell	5,832 -4,068	-41%	-$569K	0.01%	636
2015 Q2	$1.42M	Sell	9,900 -6,500	-40%	-$927K	0.01%	490
2015 Q1	$2.31M	Buy	+16,400	New	+$2.52M	0.02%	380

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

FCH

Freestone Capital Holdings Seattle, Washington $3.86B AUM 26.3% 1-Year Est. Return

HBK Investments's TARO Position: Q4 2018 in Review

HBK Investments sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2018, closing a stake of 2,800 shares — an estimated $275K sold.

HBK Investments first reported a position in TARO in Q1 2015 and held it in 9 quarters. The position peaked at $4.67M in Q2 2016. 94 funds tracked by Wall St. Rank hold TARO as of Q4 2018.

HBK Investments reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2018 after selling out during the quarter.
HBK Investments sold 2,800 Taro Pharmaceutical Industries Ltd. shares in Q4 2018, an estimated $275K.
HBK Investments first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2015 and held it in 9 quarters.
HBK Investments's Taro Pharmaceutical Industries Ltd. position peaked at $4.67M in Q2 2016.
94 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2018.

Based on HBK Investments's 13F filing for Q4 2018, filed 14 Feb 2019.